Blepharophimosis-intellectual disability syndrome, Ohdo type

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2728OMIM:249620Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Blepharophimosis-intellectual disability syndrome, Ohdo type (also known as Ohdo syndrome or Ohdo blepharophimosis syndrome) is a rare genetic disorder first described by Ohdo and colleagues in 1986. It is characterized by a distinctive combination of facial features, intellectual disability, and congenital anomalies. The hallmark facial feature is blepharophimosis, a narrowing of the eye opening due to small palpebral fissures, often accompanied by ptosis (drooping eyelids). Affected individuals typically present with intellectual disability of variable severity, which may range from mild to severe. Additional features can include a mask-like, expressionless face, a broad and flat nasal bridge, small mouth, and dental anomalies. Congenital heart defects have been reported in some patients, and hearing loss may also occur. The condition affects multiple body systems, including the craniofacial structures, central nervous system, cardiovascular system, and musculoskeletal system. Hypotonia (reduced muscle tone) and feeding difficulties may be present in infancy. Growth may be affected, with some individuals showing short stature. Speech and motor development are typically delayed. The Ohdo type should be distinguished from other forms of blepharophimosis-intellectual disability syndromes, including the Say-Barber-Biesecker-Young-Simpson (SBBYS) variant, which is caused by mutations in the KAT6B gene and has overlapping but distinct features. There is currently no cure or disease-specific treatment for Ohdo-type blepharophimosis-intellectual disability syndrome. Management is supportive and multidisciplinary, focusing on the individual's specific symptoms. This may include surgical correction of ptosis or blepharophimosis to improve vision and appearance, cardiac evaluation and management if heart defects are present, hearing aids for hearing impairment, and early intervention programs including speech therapy, physical therapy, and special education to optimize developmental outcomes. Regular follow-up with a clinical geneticist and relevant specialists is recommended.

Also known as:

Clinical phenotype terms— hover any for plain English:

Hypoplasia of teethHP:0000685Abnormal palmar dermatoglyphicsHP:0001018
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Blepharophimosis-intellectual disability syndrome, Ohdo type.

View clinical trials →

No actively recruiting trials found for Blepharophimosis-intellectual disability syndrome, Ohdo type at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Blepharophimosis-intellectual disability syndrome, Ohdo type community →

No specialists are currently listed for Blepharophimosis-intellectual disability syndrome, Ohdo type.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Blepharophimosis-intellectual disability syndrome, Ohdo type.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Blepharophimosis-intellectual disability syndrome, Ohdo typeForum →

No community posts yet. Be the first to share your experience with Blepharophimosis-intellectual disability syndrome, Ohdo type.

Start the conversation →

Latest news about Blepharophimosis-intellectual disability syndrome, Ohdo type

No recent news articles for Blepharophimosis-intellectual disability syndrome, Ohdo type.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Blepharophimosis-intellectual disability syndrome, Ohdo type

What is Blepharophimosis-intellectual disability syndrome, Ohdo type?

Blepharophimosis-intellectual disability syndrome, Ohdo type (also known as Ohdo syndrome or Ohdo blepharophimosis syndrome) is a rare genetic disorder first described by Ohdo and colleagues in 1986. It is characterized by a distinctive combination of facial features, intellectual disability, and congenital anomalies. The hallmark facial feature is blepharophimosis, a narrowing of the eye opening due to small palpebral fissures, often accompanied by ptosis (drooping eyelids). Affected individuals typically present with intellectual disability of variable severity, which may range from mild to

How is Blepharophimosis-intellectual disability syndrome, Ohdo type inherited?

Blepharophimosis-intellectual disability syndrome, Ohdo type follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Blepharophimosis-intellectual disability syndrome, Ohdo type typically begin?

Typical onset of Blepharophimosis-intellectual disability syndrome, Ohdo type is neonatal. Age of onset can vary across affected individuals.